CRISPR Therapeutics treats first patient with gene editing tech; Amicus nabs 'breakthrough' status for Pompe drug
→ The long awaited first-in-human testing of CRISPR gene editing tech — if you skip past the recent controversial …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
